SCHEMBL11399731

SCHEMBL11399731

CCOC(=O)Nc1ccc(C(=O)OCC)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ HPGD P15428 2/20 0.49
▸ CRHBP P24387 1/20 0.49
▸ CRHR2 Q13324 1/20 0.49
▸ NAMPT P43490 1/20 0.48
▸ P4HTM Q9NXG6 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ CYP1A2 P05177 2/20 0.46
▸ MTNR1B P49286 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ GABRP O00591 1/20 0.45
▸ GABRD O14764 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1810634 0.88 NAMPT (0.45) NPC1RAB9ANAMPTP4HTMKDM4E
SCHEMBL20379645 0.85 MAPT (0.54) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL30112066 0.83 CYP1A2 (0.47) NPC1RAB9AHPGDP4HTMKDM4E
SCHEMBL19555950 0.83 CYP1A2 (0.47) NPC1RAB9AHPGDP4HTMKDM4E
SCHEMBL29031095 0.82 SMN1; SMN2 (0.67) NPC1RAB9AP4HTMSMN1; SMN2HTT
SCHEMBL28844082 0.82 KDM4E (0.49) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL7896726 0.81 KCNQ3 (0.54) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL9673301 0.81 SMN1; SMN2 (0.54) NPC1RAB9AHPGDCRHBPCRHR2
SCHEMBL29031128 0.81 SMN1; SMN2 (0.47) NPC1RAB9AHPGDP4HTMKDM4E
SCHEMBL28543158 0.79 SMN1; SMN2 (0.53) NPC1RAB9AHPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4273779-A Treating hypertension with substituted-5-amino-2-pyridinecarboxylic acids CIBA-GEIGY CORPORATION (US) 1981-06-16 — — US disclosed
Send feedback